CLINICAL STUDY

Coronary Artery Disease Learning and Algorithm Development (CADLAD) Clinical Study

At Analytics 4 Life, we are committed to developing a revolutionary form of cardiac imaging for CAD by machine learning from using paired physiologic data and gold standard results, all completely source-verified from participating sites.

A two-stage study is being conducted to develop and compare the performance of a machine-learned algorithm to detect cardiac health affected by the presence of CAD by pairing a patient’s physiologic signals with their cardiac catheterization results.

A clinical diagnosis of significant coronary artery disease is defined as either a ≥ 70% stenosis or a reduced fractional flow rate of <0.80 in the major coronary arteries and their distributions, including the left main artery (LMA), left anterior descending artery (LAD), circumflex artery (LCX), and the right coronary artery (RCA).

Caution—Investigational Device. Limited by Federal Law to Investigational Use. CorVista is not available for commercial distribution.

OUR DEDICATED CLINICAL TEAM

Guided by a proven team with decades of medical device, clinical, and regulatory experience

Meet Our Team

Study Locations

 Atlanta heart specialists Austin Heart (approved) Bryan-Heart-300x168 Bryan-Heart-300x168 LeBauer Lexington New Hanover N. Georgia (clear) Piedmont Piedmont Rochester